Accelerated approval requirements for lurbinectedin

Saved in:
Bibliographic Details
Published inThe lancet oncology Vol. 23; no. 5; p. e206
Main Authors Benjamin, David J, Prasad, Vinay
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.05.2022
Elsevier Limited
Subjects
Cancer
Carbolines - adverse effects
FDA approval
Heterocyclic Compounds, 4 or More Rings - adverse effects
Humans
Hypothesis testing
Medical prognosis
United States > US
Online AccessGet full text

Cover

More Information
ISSN:1470-2045
1474-5488
DOI:10.1016/S1470-2045(22)00193-0